… taking different NOACs (rivaroxaban, dabigatran, apixaban, … Among them, apixaban seemed
to bring about the lowest risk of … ] had analyzed the GIB risk of standard-dose and low-dose …

… In this study, we investigate the survival benefits of low-dose … of thromboembolism and
hemorrhage in patients with non-valvular AF (… dabigatran and apixaban, for the warfarin group and …

… Non-valvular atrial fibrillation (NVAF) is a common cardiac … Four DOACs (dabigatran,
rivaroxaban, apixaban, and … In some patients taking very low-dose dabigatran (75 mg twice daily), …

… , 92 patients received dabigatran, 103 rivaroxaban, 45 apixaban … group, because DOACs
are prescribed for non-valvular AF … consider dabigatran to be the better alternative for warfarin …

… that apixaban may increase the risk of major bleeding. (2) Dabigatran etexilate: A study …
reported SSE was significantly lower in the rivaroxaban group and low-dose rivaroxaban …

… in multicenter hospitals are rivaroxaban and dabigatran. A total of 4191 patients with non-valvular
AF (… This study complements the blank of low dose apixaban for clinical outcomes in …

… -control strategy for non-valvular atrial fibrillation (NVAF), … study, we found that neither
rivaroxaban nor dabigatran were … and edoxaban until December 2018, so data about apixaban …

… major bleeding comparing apixaban to VKAs, apixaban to … apixaban compared to warfarin,
dabigatran, and rivaroxaban. … either dabigatran or rivaroxaban when compared to apixaban. …

… included Japanese patients aged ≥80 years found low-dose … of rivaroxaban, apixaban and
edoxaban, but not dabigatran, … with warfarin, rivaroxaban and apixaban use in AF patients …

… Dabigatran, rivaroxaban, or edoxaban were used at lower doses, while apixaban was used
at standard dose in patients with atrial … , especially with the use of warfarin. Asians have a …